The
wound healing
company

The pioneer in synthetic skin technology

Accelerate the 
shift to Synthetics

We are improving wound care for patients, health care professionals (HCPs), and society through the use of innovative polylactide technology.

What are the benefits?

safe, proven

Available in more than 40 countries and more than 250,000 patients treated …

Read more → Read more

safe, proven

optimized, reproducible

PMI’s  synthetic skin substitutes are not based on biological materials …

Read more → Read more

optimized, reproducible

biodegradable, absorbable

With its unique structure the matrix is 100% biodegradable and completely metabolizes to H₂O and CO₂ …

Read more → Read more

biodegradable, absorbable

Engineered
Polylactide
Technology

SUPRA EPT™ is the proprietary Engineered Polylactide Technology that is the basis of our innovative range of synthetic wound healing products. Polylactic acid polymers form the basis of this pioneering technology.

An industry pioneer

PolyMedics Innovations (PMI) was founded to develop, produce, and commercialise innovative biomaterials and systems for wound treatment …

A quicker return to normality

Clinically proven effective pain relief, fast wound healing, and significant improvement in treatment outcomes for thousands of patients …

Worldwide presence

With distribution in over 40 countries, come join us at medical meetings around the world …

The proven synthetic skin substitute technology

0

Total
publications

0

Relevant
trials

0

RCTs

0

Cohort

0

case series/
case report

Note: Relevant Trials: Trials that are used to substantiate the claims according to the PRISMA analysis. RCTs: Randomised controlled trials. Cohort: Non-randomised, controlled studies.

— V1 February 2025 —